China Digest: Drug developer Hope nets $56m; biotech firm Yikon raises $39m

China Digest: Drug developer Hope nets $56m; biotech firm Yikon raises $39m

Source: Laurynas Mereckas/Unsplash

06 May, 2021

Grand Flight Investment Hope Medicine Qiming Venture Partners Yikon Genomics Yunfeng Capital

Printed by Unregistered user on Sun, 27 Jul 2025 12:19:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China Digest: RTFKT Studios raises $8m; Foodpanda sets up Taiwan tech hub

Venture Capital

China Deal Review: Dealmaking stages a comeback in March as startups raise over $11.4b

Read more from Greater China

Editor’s Take: The Week That Was—July 21-26

Hong Kong IPO boom triggers price war among banks